Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,446 | 199 | 96.8% |
| Education | $113.88 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $559.65 | 36 | $0 (2024) |
| PFIZER INC. | $335.24 | 21 | $0 (2023) |
| Novo Nordisk Inc | $248.41 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $234.16 | 17 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $216.28 | 13 | $0 (2024) |
| Amgen Inc. | $197.66 | 4 | $0 (2024) |
| ABBVIE INC. | $178.92 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $159.76 | 11 | $0 (2021) |
| GlaxoSmithKline, LLC. | $158.95 | 10 | $0 (2023) |
| Lilly USA, LLC | $153.49 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472.64 | 17 | Amgen Inc. ($150.00) |
| 2023 | $364.95 | 19 | GlaxoSmithKline, LLC. ($55.90) |
| 2022 | $382.45 | 21 | Biohaven Pharmaceutical Holding Company Ltd. ($71.94) |
| 2021 | $609.48 | 38 | Biohaven Pharmaceuticals, Inc. ($98.21) |
| 2020 | $375.14 | 25 | AstraZeneca Pharmaceuticals LP ($98.57) |
| 2019 | $412.64 | 27 | AstraZeneca Pharmaceuticals LP ($179.48) |
| 2018 | $463.48 | 26 | PFIZER INC. ($139.60) |
| 2017 | $479.11 | 28 | Astellas Pharma US Inc ($118.01) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 9 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/17/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,010 | 1,712 | $149,752 | $71,756 |
| 2022 | 17 | 1,031 | 1,773 | $156,918 | $73,453 |
| 2021 | 16 | 1,099 | 2,047 | $179,352 | $86,025 |
| 2020 | 17 | 1,503 | 2,676 | $248,375 | $99,961 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 50 | 50 | $1,750 | $872.50 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 21 | $2,100 | $855.52 | 40.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 152 | 218 | $3,052 | $736.20 | 24.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 41 | 51 | $2,040 | $386.14 | 18.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 61 | 66 | $660.00 | $191.00 | 28.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 15 | $750.00 | $119.24 | 15.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 37 | $555.00 | $38.79 | 7.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 16 | 64 | $1,280 | $17.84 | 1.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 239 | 658 | $96,726 | $53,144 | 54.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 156 | 156 | $39,000 | $19,473 | 49.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 91 | $9,100 | $4,198 | 46.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 29 | 29 | $2,320 | $1,893 | 81.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 88 | 196 | $7,840 | $1,865 | 23.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 57 | 207 | $7,452 | $1,825 | 24.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 190 | 296 | $4,144 | $1,009 | 24.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 42 | 42 | $1,890 | $661.25 | 35.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 42 | 67 | $2,680 | $458.77 | 17.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 36 | 38 | $2,280 | $397.32 | 17.4% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 12 | 12 | $540.00 | $312.07 | 57.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 29 | 30 | $1,500 | $256.22 | 17.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $630.00 | $222.06 | 35.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 64 | 68 | $680.00 | $204.00 | 30.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 13 | 58 | $870.00 | $76.68 | 8.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 17 | 85 | $1,700 | $30.14 | 1.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 309 | 811 | $124,341 | $51,557 | 41.5% |
About Dr. Roy Deen, M.D
Dr. Roy Deen, M.D is a Family Medicine healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437263340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Deen, M.D has received a total of $3,560 in payments from pharmaceutical and medical device companies, with $472.64 received in 2024. These payments were reported across 201 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,446).
As a Medicare-enrolled provider, Deen has provided services to 4,643 Medicare beneficiaries, totaling 8,208 services with total Medicare billing of $331,195. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Milledgeville, GA
- Active Since 08/18/2006
- Last Updated 05/18/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437263340
Products in Payments
- FARXIGA (Drug) $328.97
- XIFAXAN (Drug) $216.28
- XARELTO (Drug) $179.19
- NURTEC ODT (Drug) $170.15
- KRYSTEXXA (Biological) $150.00
- SYMBICORT (Drug) $138.44
- CHANTIX (Drug) $136.69
- TRELEGY ELLIPTA (Drug) $133.15
- VRAYLAR (Drug) $118.71
- ELIQUIS (Drug) $118.19
- TRINTELLIX (Drug) $104.77
- Ozempic (Drug) $93.85
- TRADJENTA (Drug) $83.74
- QUVIVIQ (Drug) $83.67
- MOUNJARO (Drug) $67.89
- Tresiba (Drug) $65.82
- Rybelsus (Drug) $57.26
- INVOKANA (Drug) $54.97
- TRULICITY (Drug) $53.74
- Cologuard Collection Kit (Device) $52.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Milledgeville
Dr. Michael Duke, M.d, M.D
Family Medicine — Payments: $7,953
Dr. James Smith, M.d, M.D
Family Medicine — Payments: $7,636
Elizabeth Furbish, Md, MD
Family Medicine — Payments: $671.54
James Kelly, M.d, M.D
Family Medicine — Payments: $119.64
Dr. Charles Caulton, Md, MD
Family Medicine
Dr. Ronald Boyd, Md, MD
Family Medicine